शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEShree Pacetronix Ltd· Healthcare Equipment & SuppliesHighNeutral
Announced Mon, 25 May, 2026 · 19:50 IST

Pursuant to Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the following: 1.Audited Financial Results ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+6.9%Reaction day
₹138.95
prior close
₹150.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.7%+6.2% vs market
Medical Equipment & Supplies peers, median of 10sector-1.8%+8.7% vs sector

On the reaction day the stock moved 6.2 pts more than Nifty Microcap 250 and 8.7 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-2.7
10m
-3.3
15m
+2.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+6.9+0.7+6.2-1.8+8.7
Next day
+5.7+0.7+5.0-0.5+6.2
2d
-0.3+0.0-0.3-2.8+2.6
3d
-8.6-1.1-7.5-5.0-3.6
4d
-3.2+0.0-3.2-7.5+4.3
5d
+2.9+0.3+2.7-4.9+7.8
1w
+4.4+1.1+3.2-7.1+11.4
15d
+1.5+4.9-3.4-7.7+9.1
1m
-8.6+5.3-13.9-2.3-6.3
2m
-10.7+6.9-17.6+0.1-10.8
3m
-1.1+11.9-13.0-4.7+3.6
UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 10Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shree Pacetronix Ltd has submitted its audited annual financial results for FY2025-26, covering both standalone and consolidated financials. The auditor S R Naredi & Company has issued an unqualified/clean opinion, stating the financial statements give a true and fair view. The company's only business segment is 'Life Saving Devices'. During the year, the company allotted 75,150 equity shares upon conversion of warrants. The consolidated results include subsidiary Shree Coratomic Ltd, which reported nominal revenue of Rs. 1.75 lakh and a net loss of Rs. 0.70 lakh for the year. Total consolidated assets stood at Rs. 2,570.74 lakh, up from Rs. 2,303.74 lakh in the previous year.

Likely market impact

The clean audit opinion and absence of qualifications or emphasis of matter paragraphs are positive signals for investors. Share dilution from warrant conversion is modest at 75,150 shares. The subsidiary's negligible contribution suggests minimal impact on consolidated performance.